End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-14 EDT
|
5-day change
|
1st Jan Change
|
12.8
CNY
|
+2.81%
|
|
-12.45%
|
-14.27%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,624
|
1,521
|
2,347
|
4,297
|
3,644
|
2,461
|
Enterprise Value (EV)
1 |
1,572
|
1,860
|
2,966
|
4,827
|
4,328
|
3,357
|
P/E ratio
|
45.3
x
|
231
x
|
-585
x
|
32.4
x
|
33.6
x
|
-61.2
x
|
Yield
|
0.75%
|
0.26%
|
-
|
0.2%
|
0.35%
|
0.67%
|
Capitalization / Revenue
|
1.44
x
|
1.59
x
|
2.34
x
|
2.96
x
|
2.34
x
|
1.36
x
|
EV / Revenue
|
1.39
x
|
1.95
x
|
2.95
x
|
3.33
x
|
2.78
x
|
1.85
x
|
EV / EBITDA
|
22.3
x
|
36.6
x
|
46.8
x
|
20.3
x
|
19.2
x
|
26.9
x
|
EV / FCF
|
-12.8
x
|
-8.25
x
|
-25.3
x
|
-27.3
x
|
-20.9
x
|
-13.5
x
|
FCF Yield
|
-7.79%
|
-12.1%
|
-3.96%
|
-3.67%
|
-4.78%
|
-7.39%
|
Price to Book
|
1.87
x
|
1.8
x
|
2.81
x
|
3.81
x
|
2.91
x
|
2.01
x
|
Nbr of stocks (in thousands)
|
153,672
|
153,112
|
152,654
|
162,948
|
162,948
|
164,847
|
Reference price
2 |
10.57
|
9.937
|
15.37
|
26.37
|
22.36
|
14.93
|
Announcement Date
|
19-04-11
|
20-03-24
|
21-04-22
|
22-03-14
|
23-02-20
|
24-04-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,127
|
954.4
|
1,004
|
1,450
|
1,554
|
1,814
|
EBITDA
1 |
70.35
|
50.83
|
63.3
|
237.6
|
225.6
|
124.6
|
EBIT
1 |
39.65
|
11.81
|
11.72
|
183.6
|
159.1
|
-27.2
|
Operating Margin
|
3.52%
|
1.24%
|
1.17%
|
12.66%
|
10.24%
|
-1.5%
|
Earnings before Tax (EBT)
1 |
41.91
|
1.122
|
-8.515
|
160.4
|
121
|
-72.94
|
Net income
1 |
35.73
|
6.554
|
-3.882
|
131.8
|
109.6
|
-35.29
|
Net margin
|
3.17%
|
0.69%
|
-0.39%
|
9.09%
|
7.05%
|
-1.95%
|
EPS
2 |
0.2334
|
0.0431
|
-0.0263
|
0.8134
|
0.6659
|
-0.2438
|
Free Cash Flow
1 |
-122.5
|
-225.6
|
-117.4
|
-177
|
-206.8
|
-248.2
|
FCF margin
|
-10.86%
|
-23.63%
|
-11.69%
|
-12.2%
|
-13.31%
|
-13.68%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0797
|
0.0263
|
-
|
0.0526
|
0.0789
|
0.1000
|
Announcement Date
|
19-04-11
|
20-03-24
|
21-04-22
|
22-03-14
|
23-02-20
|
24-04-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
338
|
619
|
531
|
684
|
895
|
Net Cash position
1 |
52.4
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
6.659
x
|
9.773
x
|
2.233
x
|
3.03
x
|
7.185
x
|
Free Cash Flow
1 |
-122
|
-226
|
-117
|
-177
|
-207
|
-248
|
ROE (net income / shareholders' equity)
|
3.95%
|
0.69%
|
-0.48%
|
12.7%
|
8.34%
|
-4.12%
|
ROA (Net income/ Total Assets)
|
1.87%
|
0.47%
|
0.37%
|
4.8%
|
3.68%
|
-0.62%
|
Assets
1 |
1,915
|
1,386
|
-1,053
|
2,745
|
2,974
|
5,702
|
Book Value Per Share
2 |
5.670
|
5.510
|
5.460
|
6.920
|
7.700
|
7.410
|
Cash Flow per Share
2 |
1.990
|
0.7000
|
1.060
|
1.410
|
1.970
|
0.9900
|
Capex
1 |
297
|
396
|
347
|
286
|
220
|
155
|
Capex / Sales
|
26.36%
|
41.48%
|
34.6%
|
19.73%
|
14.16%
|
8.53%
|
Announcement Date
|
19-04-11
|
20-03-24
|
21-04-22
|
22-03-14
|
23-02-20
|
24-04-19
|
|
1st Jan change
|
Capi.
|
---|
| -14.27% | 284M | | +6.11% | 105B | | -4.67% | 63.83B | | +73.81% | 45.28B | | +15.46% | 38.93B | | +5.46% | 33.06B | | +11.59% | 20.21B | | +13.74% | 16.94B | | +20.05% | 16.08B | | +5.02% | 14.49B |
Other Commodity Chemicals
|